![[GUIDE BAR]](../gif/cdguide.gif)
CELLULAR FUNCTION OF CD28  
DISEASE RELEVANCE OF CD28 AND FUNCTION OF CD28 IN INTACT ANIMAL  
MOLECULAR STRUCTURE OF CD28  
| CELL TYPE | MW UNREDUCED | MW REDUCED | Comment |
|---|---|---|---|
| T lymphocytes | ~90 kDa | ~44 kDa | |
| COS cells | ~74 kDa | ~39 kDa |
POST-TRANSCRIPTIONAL MODIFICATION OF CD28  
POST-TRANSLATIONAL MODIFICATION OF CD28  
SUBSTRATES FOR CD28   - No information
ENZYMES WHICH MODIFY CD28   - No information
LIGANDS FOR CD28 AND MOLECULES ASSOCIATED WITH CD28  
| MOLECULE | COMMENT |
|---|---|
| CD80 | The CD80 molecule is also a ligand for CTLA-4, which binds with high avidity |
| CD86 | The CD86 molecule is also a ligand for CTLA-4, which binds with high avidity |
| PI3-kinase | The cytoplasmic region of CD28 binds to this intracellular signaling molecule. The pYMNM motif binds to the SH2 domains of PI3-kinase and GRB-2 |
| ITK | The cytoplasmic region of CD28 binds to this intracellular signaling molecule |
| GRB-2-SOS (signaling complex) | The cytoplasmic region of CD28 binds to this intracellular signaling molecule. The pYMNM motif binds to the SH2 domains of PI3-kinase and GRB-2 |
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| B-T3 (6T-040) | Vermot Desroches C/ J Wijdenes | |
| B-L8 (6T-041) | Vermot Desroches C/ J Wijdenes | |
| 4B10 (6T-109) | Patricia Roth Coulter |
SELECTION OF OTHER CD28-SPECIFIC REFERENCE MAB  
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| KOLT-2 | K Okubo (Nichirei) | |
| 9.3 | JA Hansen | |
| Leu28 (L293) | NL Warner (Becton Dickinson) |
REVIEWS
1. June CH,Bluestone JA,Nadler LM,Thompson CB The B7 and CD28 receptor families. Immunol Today 1994 15:321 PubMed
2. June CH,Ledbetter JA,Linsley PS,Thompson CB Role of the CD28 receptor in T-cell activation. Immunol Today 1990 11:211 PubMed
3. Linsley PS,Ledbetter JA The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993 11:191 PubMed
PRIMARY CITATIONS
4. Aruffo A,Seed B Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci U S A 1987 84:8573 PubMed
5. Hansen JA, Martin PJ and Nowinski RC. 1980. Immunogenetics 10: 247
6. Ledbetter JA,Martin PJ,Spooner CE,Wofsy D,Tsu TT,Beatty PG,Gladstone P Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J Immunol 1985 135:2331 PubMed
7. Lee KP,Taylor C,Petryniak B,Turka LA,June CH,Thompson CB The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J Immunol 1990 145:344 PubMed
8. Shahinian A,Pfeffer K,Lee KP,Kundig TM,Kishihara K,Wakeham A,Kawai K,Ohashi PS,Thompson CB,Mak TW Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993 261:609 PubMed
9. Weiss A,Manger B,Imboden J Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J Immunol 1986 137:819 PubMed
Portions copyright by Garland Press and by the International Workshops on Human Leukocyte Differentiation Antigens; used with permission
Modified 10/14/99 mpr@mail.nih.gov